openPR Logo
Press release

Cancer Tissue Diagnostics Market to Reach US$ 9648.9 Mn by 2026-End

06-19-2018 09:16 AM CET | Health & Medicine

Press release from: Future Market Insights

Cancer Tissue Diagnostics Market to Reach US$ 9648.9 Mn

The National Cancer Institute (NCI), which is a part of National Institutes of Health (NIH) in the US estimated 1,685,210 new cases of cancer in the country in 2016. In the same year, NCI also projected 595,690 deaths due to carcinogenic ailments. Cancer research activities have surged rapidly over the past few years, which has led to more product approvals for cancer diagnostic and treatment purposes. A recent study conducted by Future Market Insights (FMI) reveals that the global cancer tissue diagnostics market, which is currently valued at over US$ 4345 Mn, will expand at a healthy CAGR of 8.3% during the forecast period (2016-2026). During these ten years of the forecast, the global demand for cancer tissue diagnostics is expected to grow by leaps and bounds as diagnostic technologies will continue to get more efficient and credible.

FMI’s report titled “Cancer Tissue Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016–2026” also cites that North America represents the most lucrative market for cancer tissue diagnostics, followed by Europe and APAC. In 2016, North America accounted for more than 36% share of the global market. The cancer tissue diagnostics market in this region is expected to reach a valuation of US$ 4,017.7 Mn towards the end of 2026. This growth is primarily attributed to factors such as the constantly extending list of cancer biomarkers and the presence of advance healthcare infrastructures in the region. Meanwhile, Asia Pacific excluding Japan (APEJ) is also anticipated to witness a strong growth of its market over the next couple of years. By 2026-end, the region’s market is expected to reach US$ 1,107.7 Mn in terms of revenue.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-4191

The report further projects that in situ hybridization will continue to be the leading cancer tissue diagnostics type. In terms of revenue, in situ hybridization tests are projected to account for the largest share of the market during the assessment period. Cases of breast cancer have been quite high amongst all the cancers type of late. Hence, procedures for breast cancer diagnostics are expected to remain relatively higher than for other cancer types in 2017 and beyond.

Key Factors Boosting the Global Cancer Tissue Diagnostics Market Include:

Inclusion of cancer screening tests in national cancer screening programs in various countries.

Havier discretionary funding for cancer research that is resulting in the development of more efficient diagnostic procedures.

Arrival of revolutionary second and third -generation diagnostics platforms that are quickly gaining popularity in the market.

Novelty in imaging techniques and availability of affordable diagnostics.

Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Ventana Medical Systems, Inc, Bio Rad Laboratories Inc., Enzo Life Sciences, Inc., Abcam plc., BioGenex, Cell Signaling Technology, Inc., Agilent Technologies, Inc., PerkinElmer Inc. are some of the prominent companies operating in the global market for cancer tissue diagnostics. Many of these market players are implementing merger and acquisition strategies to increase their market presence. Furthermore, cancer diagnostic assay kits developers, instrument manufacturers and technology license providers are also partnering with each other in order to increase their consumer base.

Request Report TOC @ https://www.futuremarketinsights.com/askus/rep-gb-4191

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Tissue Diagnostics Market to Reach US$ 9648.9 Mn by 2026-End here

News-ID: 1087629 • Views:

More Releases from Future Market Insights

Boron Carbide Market Set for 5.3% Growth Surge by 2035 as Manufacturers Embrace Next-Generation Applications
Boron Carbide Market Set for 5.3% Growth Surge by 2035 as Manufacturers Embrace …
The global boron carbide market is entering a transformative decade. Valued at USD 177.6 million in 2025 and projected to reach USD 298.4 million by 2035, the industry is expected to expand at a compound annual growth rate (CAGR) of 5.3%. From defense armor to nuclear energy systems, from aerospace innovation to electronic components, boron carbide's unmatched hardness, lightweight structure, and high heat resistance are positioning it as a cornerstone
In-Vehicle Ethernet System Market to Grow 3.9X by 2035, Powering the Future of Connected and Autonomous Mobility
In-Vehicle Ethernet System Market to Grow 3.9X by 2035, Powering the Future of C …
The global in-vehicle Ethernet system market is poised for transformative growth, rising from USD 3.5 billion in 2025 to USD 13.9 billion by 2035, at a compound annual growth rate (CAGR) of 14.6%. This surge reflects the automotive industry's evolution toward high-speed connectivity, safety-focused innovation, and software-defined vehicle architectures. Buy Now & Save: Premium Market Report at $5,000 | Discount Details Inside:- https://www.futuremarketinsights.com/reports/sample/rep-gb-2094 Ethernet technology, once limited to enterprise networks, now forms
Automotive Windshield Washer System Market Accelerates Toward USD 5.4 Billion by 2035: Innovation and Safety Drive Growth
Automotive Windshield Washer System Market Accelerates Toward USD 5.4 Billion by …
The global automotive windshield washer system market is entering a new era of growth and transformation. Valued at USD 3,512 million in 2025, the market is projected to expand at a steady compound annual growth rate (CAGR) of 4.5%, achieving USD 5,448.6 million by 2035. This upward trajectory is being shaped by advancements in safety regulations, increasing integration of driver assistance technologies, and the rising sophistication of automotive design across
Controlled and Slow Release Fertilizers Market to Double by 2035, Fueling Sustainable Agricultural Growth
Controlled and Slow Release Fertilizers Market to Double by 2035, Fueling Sustai …
The global Controlled and Slow Release Fertilizers (CSRF) market is poised for remarkable expansion, with sales projected to rise from USD 7,621.2 million in 2025 to USD 15,958.6 million by 2035, reflecting a robust compound annual growth rate (CAGR) of 7.6%. This trajectory underscores a decade of transformation where manufacturers, driven by efficiency, innovation, and environmental stewardship, will redefine how fertilizers power global food systems. Buy Now & Save: Premium Market

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For